Zobrazeno 1 - 10
of 29
pro vyhledávání: '"Valerie Arnold"'
Autor:
Valerie Arnold, Sonia Ancoli-Israel, Thien Thanh Dang-Vu, Kazuo Mishima, Kate Pinner, Manoj Malhotra, Margaret Moline
Publikováno v:
Neurology and Therapy, Vol 13, Iss 4, Pp 1081-1098 (2024)
Abstract Background Pharmacologic treatments are available to treat insomnia, a common and burdensome sleep disorder, but may be contraindicated in older adults who are prone to side effects from sleep-promoting drugs. These analyses of sleep diary d
Externí odkaz:
https://doaj.org/article/23ca3d2e802c4505a3c5dd1335916d83
Publikováno v:
Journal of Child and Adolescent Psychopharmacology. 32:98-106
Publikováno v:
Journal of International Management Studies. 22:20-26
Autor:
Valerie Arnold, Stephen V. Faraone, Elias H. Sarkis, Ann C. Childress, Andrew J. Cutler, Steve Caras, Joel L. Young, C. Brendan Montano
Publikováno v:
The Journal of clinical psychiatry. 82(5)
Objective: To assess the efficacy and safety of AR19 in the treatment of attention-deficit/hyperactivity disorder (ADHD) diagnosed by DSM-5 criteria in adults from 18 through 55 years of age. AR19 is a pellets-in-capsule, immediate-release amphetamin
Publikováno v:
Journal of Child and Adolescent Psychopharmacology
Objectives: In a previous pivotal study of children and adolescents (aged 6–17 years) with attention-deficit/hyperactivity disorder (ADHD), dose-optimized SHP465 mixed amphetamine salts (MAS) extended-release (12.5–25 mg once daily) was superior
Autor:
Bev Incledon, Valerie Arnold, Floyd R. Sallee, Michelle D. Po, Ann C. Childress, Ryan Gregg, Frank A. Lopez
Publikováno v:
Journal of the American Academy of Child & Adolescent Psychiatry. 60:S257
Autor:
Ann C. Childress, Valerie Arnold, Bryan Dirks, John Shepski, Ben Adeyi, Brian Scheckner, Thomas Babcock, Robert A. Lasser, Frank A. Lopez
Publikováno v:
Journal of Attention Disorders. 21:52-61
Objective: To describe symptom rebound in children with ADHD treated with lisdexamfetamine dimesylate (LDX) or placebo. Method: During a 4-week, randomized, double-blind, placebo-controlled trial of LDX, parents/caregivers completed the Conners’ Pa
Publikováno v:
Journal of the American Academy of Child & Adolescent Psychiatry. 58:S252
Publikováno v:
Postgraduate Medicine. 127:323-329
Attention-deficit/hyperactivity disorder (ADHD) is often undiagnosed and undertreated in adults, resulting in wide-ranging problems and functional deficits in patients' lives. In addition, psychiatric comorbidities unrelated to symptom severity may b
Autor:
Valerie Arnold, Richard H. Weisler, Ming Yu, Brigitte Robertson, Margo Jaffee, Brian Yan, Michael Greenbaum
Publikováno v:
CNS Drugs
Objective The objective of this randomized, double-blind, placebo-controlled study was to evaluate the efficacy and safety of SHP465 mixed amphetamine salts (MAS) in adults with attention-deficit/hyperactivity disorder (ADHD). Methods Eligible adults